60 mg dose ticagrelor provides stronger platelet inhibition than clopidogrel in Chinese patients with chronic coronary syndrome: A randomized, single-blind, crossover study

•This was a randomized, single-blind, cross-over study in Chinese patients.•Ticagrelor exhibits more potent antiplatelet aggregation compared with clopidogrel.•60 mg QD ticagrelor had a stronger inhibitory effect than clopidogrel.

Bibliographische Detailangaben

Veröffentlicht in:	Thrombosis research 2020-06, Vol.190, p.60-61
Hauptverfasser:	He, Meijiao, Zhang, Yun, Yan, Wei, Liu, Guangzhong, Sun, Danghui, Yuan, Yue, Shi, Jing, Kong, Yihui, Li, Yue
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular System & Cardiology Hematology Life Sciences & Biomedicine Peripheral Vascular Disease Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!